157 related articles for article (PubMed ID: 4573184)
1. [Tetanus prophylaxis using purified hyperimmune sera. 1. Study of proteolysed equine antitoxin catabolism in laboratory animals].
Depelchin A
Ann Inst Pasteur (Paris); 1972 Nov; 123(5):681-94. PubMed ID: 4573184
[No Abstract] [Full Text] [Related]
2. [Tetanus prophylaxis using purified hyper-immune sera II. Laboratory animal study of pepsin-digested horse antitoxin (author's transl)].
Depelchin A
Ann Immunol (Paris); 1974 Jun; 125 C(4):655-73. PubMed ID: 4141597
[No Abstract] [Full Text] [Related]
3. Tetanus prophylaxis. Experimental assay in horses, with penicillin and tetanus antitoxin.
Corrêa A; Tavares J
Rev Inst Med Trop Sao Paulo; 1967; 9(5):309-12. PubMed ID: 5618219
[No Abstract] [Full Text] [Related]
4. Editorial: Passive prophylaxis in tetanus.
Chakrabarty AN
J Indian Med Assoc; 1975 Mar; 64(5):128-9. PubMed ID: 1171144
[No Abstract] [Full Text] [Related]
5. [Effectiveness of allogenic and xenogenic antitoxins in the active-passive prophylaxis of tetanus in an experiment].
Nazarchuk LV
Fiziol Zh (1978); 1988; 34(4):98-101. PubMed ID: 3181517
[No Abstract] [Full Text] [Related]
6. The use of the horse tetanus antitoxin (ATS).
Bytchenko B
J Indian Med Assoc; 1975 Mar; 64(5):130-2. PubMed ID: 1151089
[No Abstract] [Full Text] [Related]
7. Letter: Passive prophylaxis in tetanus.
Kamath PG
J Indian Med Assoc; 1975 Nov; 65(10):294. PubMed ID: 1241388
[No Abstract] [Full Text] [Related]
8. A study of immunospecifically isolated tetanus antibodies.
Varró R
Ann Immunol Hung; 1973; 17():93-100. PubMed ID: 4142680
[No Abstract] [Full Text] [Related]
9. [Duration of immunity after administration of heterologous and homologous tetanus antitoxin and its enzymatical disintegration (author's transl)].
Krasemann C; Schneider W
Z Immunitatsforsch Exp Klin Immunol; 1972 Jan; 143(1):59-75. PubMed ID: 4282907
[No Abstract] [Full Text] [Related]
10. [Effectiveness of allogeneic and xenogeneic antitoxins in preventing tetanus in an experiment].
Nazarchuk LV
Fiziol Zh (1978); 1987; 33(6):83-5. PubMed ID: 3446533
[No Abstract] [Full Text] [Related]
11. [Biological properties of immunochemically pure tetanus antitoxin].
Kornilova AV; Khavkin IuA; Batalova TA; Aleksevich IaI; Baschenko IA
Zh Mikrobiol Epidemiol Immunobiol; 1983 Feb; (2):66-70. PubMed ID: 6340393
[TBL] [Abstract][Full Text] [Related]
12. Human antitoxin in prophylaxis and treatment of tetanus.
Med Lett Drugs Ther; 1965 Feb; 7(4):13-4. PubMed ID: 5831349
[No Abstract] [Full Text] [Related]
13. Studies on the antibody composition and neutralizing activity of tetanus antitoxin sera from various species of animals in relation to the antigenic substructure of the tetanus toxin molecule.
Matsuda M; Makinaga G; Hirai T
Biken J; 1983 Dec; 26(4):133-43. PubMed ID: 6204634
[TBL] [Abstract][Full Text] [Related]
14. Tetanus prophylaxis: laboratory aspects.
Smith JW
Anglo Ger Med Rev; 1969 Oct; 5():75-81. PubMed ID: 4917587
[No Abstract] [Full Text] [Related]
15. [Some experimental data on the seroprophylaxis of tetanus].
Bistoni F; Mosci L; Vecchiarelli A; Marconi P; Pitzurra M
Ann Sclavo; 1977; 19(2):285-92. PubMed ID: 603268
[TBL] [Abstract][Full Text] [Related]
16. The isolation and study of pure antitoxic antibodies by the immunosorption method.
Dalin MV; Kotova TS; Mertsalova NU
J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):120-6. PubMed ID: 4736206
[No Abstract] [Full Text] [Related]
17. Experimental study upon the efficacy of some accelerated vaccination schedules in tetanus prophylaxis.
Dimache G; Croitoru M; Durbaca S; Stoean C; Dimache A
Roum Arch Microbiol Immunol; 1993; 52(4):247-54. PubMed ID: 7827361
[TBL] [Abstract][Full Text] [Related]
18. [Anti-tetanus serum or anatoxin?].
Grosbuis S
Rev Prat; 1974 Nov; 24(51):4505-6, 4509-11. PubMed ID: 4475480
[No Abstract] [Full Text] [Related]
19. Comparative trial of three heterologous anti-tetanus sera.
Sinclair IS; McCormick JS; Clark JG
J Hyg (Lond); 1971 Jun; 69(2):201-7. PubMed ID: 5282924
[TBL] [Abstract][Full Text] [Related]
20. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
Gupta RK; Siber GR
Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
